Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia June 02, 2025 Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia
The study on the interconnection of the immune system receives the support from the CaixaResearch 2022 Program September 20, 2022 The study on the interconnection of the immune system receives the support from the CaixaResearch 2022 Program
The four new "Knowledge Generation Projects" begin at the Josep Carreras Institute: get to know them! September 08, 2022 The four new "Knowledge Generation Projects" begin at the Josep Carreras Institute: get to know them!
Checking the effectiveness of drugs with real-world epidemiological data helps determine their benefit to the patient August 31, 2022 Checking the effectiveness of drugs with real-world epidemiological data helps determine their benefit to the patient
Biological explanation discovered of why we all have a “look-alike” person August 23, 2022 Biological explanation discovered of why we all have a “look-alike” person
Leukemia vulnerability discovered causing drug sensitivity August 01, 2022 Leukemia vulnerability discovered causing drug sensitivity
A new project aims to shed new light on a frequent form of leukemia in Down Syndrome children July 21, 2022 A new project aims to shed new light on a frequent form of leukemia in Down Syndrome children
The VESIPROD team is working with Dr. Gaël Roué's lab to present its prototype to the iGEM synthetic biology competition July 20, 2022 The VESIPROD team is working with Dr. Gaël Roué's lab to present its prototype to the iGEM synthetic biology competition
A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk July 07, 2022 A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk
National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping July 05, 2022 National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping
Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation July 01, 2022 Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation
